Article

Kopcha Named Director of FDA Quality Office

October 02, 2015.

Industry veteran Michael Kopcha, a pharma was named the permanent director of FDA’s Office of Pharmaceutical Quality (OPQ) last week. He will join the Center for Drug Evaluation and Research (CDER) in November pending ethics clearance.

FDA’s OPQ was launched in January 2015 to implement processes and policies to provide better alignment among review, inspection, and research functions.

Kopcha will lead OPQ in planning and implementing strategies to drive pharmaceutical quality, with a goal of providing for an efficient pharmaceutical manufacturing sector that reliably produces high-quality medicines without extensive regulatory oversight, an FDA press release reported.

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Related Videos
Gen Li
Gen Li
Ted Sweetser
Ted Sweetser
Ted Sweetser